JOURNAL OF DRUGS IN DERMATOLOGY Journal
Overview
publication venue for
- Dermatologic Procedures for the Treatment of Seborrheic Dermatitis. 23:819-824. 2024
- Double-Blind, Placebo-Controlled Study of Onabotulinumtoxin A for the Treatment of Hailey-Hailey Disease. 22:339-343. 2023
- Skin Cancer Screening Practices Among Dermatologists: A Survey Study. 21:1235-1241. 2022
- Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel. 21:628-634. 2022
- Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis. 21:488-494. 2022
- Recapture Rate of Brodalumab in Patients With a Lapse in Treatment. 19:384-387. 2020
- Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability. 18:1218-1225. 2019
- Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials. 18:804-813. 2019
- Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice. 18:122-129. 2019
- Use of Apremilast for Aphthous Ulcers in a Patient With Behcet's Syndrome. 17:1328-1329. 2018
- Use of Apremilast for Aphthous Ulcers in a Patient With Behcet's Syndrome. 17:1328-1329. 2018
- Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients. 17:392-396. 2018
- Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection. 17:168-172. 2018
- Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. 16:760-766. 2017
- Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest. 16:438-444. 2017
- Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis. 16:127-132. 2017
- Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. 16:760-766. 2017
- Results of a Phase 2, Randomized, Vehicle-Controlled Study Evaluating the Efficacy, Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. 15:1496-1502. 2016
- The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study. 15:981-987. 2016
- Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials. 15:568-580. 2016
- Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris - a Randomized Phase III Study (PSO-FAST). 14:1468-1477. 2015
- Onychomycosis Diagnosis and Management: Perspectives from a Joint Dermatology-Podiatry Roundtable. 14:1016-1021. 2015
- Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). 14:58-66. 2015
- GLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa 2026
- Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis 2026
- The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States 2025
- Disparities in Alopecia Areata and Vitiligo FDA-Approved Therapies in Medicaid Formularies 2025
- Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry 2020
- Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab. 2016
Identity
International Standard Serial Number (ISSN)
- 1545-9616